Several reports have shown that blockade of IL-6 signaling (for example, through anti-IL-6 receptor antibody) can be a potential therapeutic strategy for psychiatric disorders (Zhang et al., 2017; Zhou et al., 2017). This evidence concerns the gene IL6 and psychiatric disorder.